These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31732566)

  • 41. Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease.
    Chung SJ; Lee JJ; Ham JH; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2016 Feb; 23():62-5. PubMed ID: 26717857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy.
    Baggio HC; Segura B; Garrido-Millan JL; Marti MJ; Compta Y; Valldeoriola F; Tolosa E; Junque C
    Mov Disord; 2015 Apr; 30(5):671-9. PubMed ID: 25600482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
    Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.
    Rabinovici GD; Furst AJ; Alkalay A; Racine CA; O'Neil JP; Janabi M; Baker SL; Agarwal N; Bonasera SJ; Mormino EC; Weiner MW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ
    Brain; 2010 Feb; 133(Pt 2):512-28. PubMed ID: 20080878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease.
    Shirvan J; Clement N; Ye R; Katz S; Schultz A; Johnson KA; Gomez-Isla T; Frosch M; Growdon JH; Gomperts SN
    Neurology; 2019 Jul; 93(5):e476-e484. PubMed ID: 31243072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
    Müller ML; Albin RL; Kotagal V; Koeppe RA; Scott PJ; Frey KA; Bohnen NI
    Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease.
    van der Zee S; Müller MLTM; Kanel P; van Laar T; Bohnen NI
    Mov Disord; 2021 Mar; 36(3):642-650. PubMed ID: 33137238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
    Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
    JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of demotivation and affective disorders in apathy in patients with Parkinson's disease without dementia and depression].
    Delgadillo-Iniguez D; Derouesné C; Lacomblez L; Gély-Nargeot MC
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Jun; 11(2):197-207. PubMed ID: 23803637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.
    Fiorenzato E; Biundo R; Cecchin D; Frigo AC; Kim J; Weis L; Strafella AP; Antonini A
    J Alzheimers Dis; 2018; 66(1):229-237. PubMed ID: 30282359
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson's disease.
    Ceccarini J; Casteels C; Ahmad R; Crabbé M; Van de Vliet L; Vanhaute H; Vandenbulcke M; Vandenberghe W; Van Laere K
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2348-2357. PubMed ID: 31342135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta amyloid deposition and cognitive decline in Parkinson's disease: a study of the PPMI cohort.
    Mihaescu AS; Valli M; Uribe C; Diez-Cirarda M; Masellis M; Graff-Guerrero A; Strafella AP
    Mol Brain; 2022 Sep; 15(1):79. PubMed ID: 36100909
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
    Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
    Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo detection of monoaminergic degeneration in early Parkinson disease by (18)F-9-fluoropropyl-(+)-dihydrotetrabenzazine PET.
    Lin SC; Lin KJ; Hsiao IT; Hsieh CJ; Lin WY; Lu CS; Wey SP; Yen TC; Kung MP; Weng YH
    J Nucl Med; 2014 Jan; 55(1):73-9. PubMed ID: 24287322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid imaging of Lewy body-associated disorders.
    Foster ER; Campbell MC; Burack MA; Hartlein J; Flores HP; Cairns NJ; Hershey T; Perlmutter JS
    Mov Disord; 2010 Nov; 25(15):2516-23. PubMed ID: 20922808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.